Explore
Validate
Learn
ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- D048-3 - Provider product page
- Provider
- R&D Systems
- Product name
- Mouse IL-18/IL-1F4 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. This antibody reacts with mouse IL-18 on Immunoprecipitation.
- Reactivity
- Mouse
- Host
- Rat
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 93-10C
- Vial size
- 100 ug
- Storage
- This antibody solution is stable for one year from the date of purchase when stored at -20 °C.
Submitted references Protein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent manner.
Hypoxia induced mitogenic factor (HIMF) triggers angiogenesis by increasing interleukin-18 production in myoblasts.
Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.
IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.
Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation.
Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Spalinger MR, Schmidt TS, Schwarzfischer M, Hering L, Atrott K, Lang S, Gottier C, Geirnaert A, Lacroix C, Dai X, Rawlings DJ, Chan AC, von Mering C, Rogler G, Scharl M
The Journal of clinical investigation 2019 May 20;129(6):2527-2541
The Journal of clinical investigation 2019 May 20;129(6):2527-2541
Hypoxia induced mitogenic factor (HIMF) triggers angiogenesis by increasing interleukin-18 production in myoblasts.
Su CM, Wang IC, Liu SC, Sun Y, Jin L, Wang SW, Lee HP, Tseng WP, Tang CH
Scientific reports 2017 Aug 7;7(1):7393
Scientific reports 2017 Aug 7;7(1):7393
Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.
Gableh F, Saeidi M, Hemati S, Hamdi K, Soleimanjahi H, Gorji A, Ghaemi A
Journal of biomedical science 2016 Jan 25;23:16
Journal of biomedical science 2016 Jan 25;23:16
IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.
Valcárcel M, Carrascal T, Crende O, Vidal-Vanaclocha F
The Journal of investigative dermatology 2014 Feb;134(2):470-480
The Journal of investigative dermatology 2014 Feb;134(2):470-480
Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation.
Chandrasekar B, Patel DN, Mummidi S, Kim JW, Clark RA, Valente AJ
The Journal of biological chemistry 2008 Feb 15;283(7):4200-9
The Journal of biological chemistry 2008 Feb 15;283(7):4200-9
Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Kamath AT, Sheasby CE, Tough DF
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 15;174(2):767-76
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 15;174(2):767-76
Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Kamath AT, Sheasby CE, Tough DF
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 15;174(2):767-76
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 15;174(2):767-76
No comments: Submit comment
No validations: Submit validation data